Revisiting the CATIE schizophrenia study. Although questions remain, some clinical guidance has emerged.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006287:Health Planning Guidelines; D006801:Humans; D010546:Perphenazine / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D010546:Perphenazine